• Mashup Score: 2

    Liver biopsy sample evaluation is an essential part of clinical studies in nonalcoholic steatohepatitis (NASH) and is key in excluding confounding morbidities. Current scoring systems, which are decisive for study inclusion, rely on imprecisely defined histological features, leading to a high observer variability of disease categorization. In this News & Views, measures to overcome these…

    Tweet Tweets with this article
    • New News&Views online! Thomas Longerich & Peter Schirmacher examine the reliability of #liver #biopsies in #NASH clinical studies for excluding confounding morbidities and the limitations of current scoring systems. Find out more here: https://t.co/nD4t0v8y7Z https://t.co/bgjaVKQfE7